Strategies for Advancing Molecular Glue Drug Discovery
In this webinar, WuXi Biology scientists showcase our end-to-end molecular glue discovery platform. Molecular glues act as “molecular adhesives”, facilitating or stabilizing interactions between proteins that might not otherwise bind strongly or at all. Molecular glues show great potential for treating diseases such as cancer and infectious, inflammatory, and neurodegenerative diseases.
Using advanced screening technologies, assays, and cutting-edge animal models, our experts discuss how this platform allows for extensive in vitro and in vivo characterization of molecular glue molecules. This webinar offers an in-depth perspective on strategies crucial for accelerating research focused on the development and optimization of these unique molecules.
Related Content
High-throughput screening (HTS) remains a foundational technology in early drug discovery, responsible for identifying approximately one-third of today’s clinical candidates....
VIEW RESOURCEHigh-throughput screening (HTS) remains critical for early drug discovery, yet traditional biochemical assays and specialized techniques such as affinity selection...
VIEW RESOURCE
